About AmplifyBio
AmplifyBio is a private company based in West Jefferson, Ohio, incorporated in 2021 in Delaware. It has reported $229,750,000 raised in three offerings on Form D since May 2021. Its chief executive is James Ganjei.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 31, 2023 | Nov 15, 2023 | $49,750,000of $100.0M target | 4 | $12.4M | EquityRule 506(b) | Form D ↗ |
| Apr 30, 2022 | Jun 29, 2022 | $100,000,000fully sold | 8 | $12.5M | EquityRule 506(b) | Form D ↗ |
| Apr 30, 2021 | May 27, 2021 | $80,000,000fully sold | 3 | $26.6M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $229,750,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on AmplifyBio's Form D filed Nov 15, 2023.
LT
Lewis Von Thaer
Director
SR
Shaun Rodriguez
Director
JG
James Ganjei
Chief Executive Officer
RN
Rohan Nirody
Director
MV
Matt Vaughan
Director
Earlier filings also listed Russell Austin (director and promoter, last listed May 2021) and Kelly Ganjei (executive officer, last listed May 2021).